These previously published data show that two of the three USB compounds (U-CH3 and U-F, also called SLC-0111) selectively bind to and inhibit the activity of the tumor-associated isoforms CA IX and XII relative to the off-target CA II [66–68]. Here, CA9 is linked to neoplasm.